Preliminary study validates deuterium MRSI's feasibility and performance in human subjects, indicating potential for clinical use.
Motivation: Deuterium MRSI is a promising clinical approach for quantifying metabolic process in human. However, the applicability of DMRSI still remains challenging due to its limited SNR at clinically available 3T. Goal(s): To validate the feasibility and performance of DMRSI on human at 5T. Approach: We built up a multi-nuclei imaging platform based upon a clinically approved human 5T system, and performed in vivo deuterium MRSI. Results: DMRS/DMRSI were successfully acquired at 5T system with good SNR and spectral resolution. 2H-water and 2H-lipid can be clearly distinguished in the DMRSI. Increased whole-brain 2H-Glx level was found in AD patient after oral intake of [6,6'-2H2]-glucose. Impact: This is the first deuterium MRS/MRSI work at a human 5T system, using a home-built multi-nuclei imaging platform. The feasibility of deuterium MRS/MRSI at 5T for clinical applications was successfully validated through in vivo human studies.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: